World representatives of the genus Arganthomyza Roháček, 2009 (Diptera, Anthomyzidae) are reviewed, keyed and their relationships are discussed on the basis of a phylogenetic analysis of morphological characters. The Nearctic species of Arganthomyza are revised, described and illustrated, and first data about their biology and distribution are given. Five new species, A. carbo sp. n. (Canada, USA), A. acuticuspis sp. n. (USA), A. bivittata sp. n. (Canada, USA), A. duplex sp. n. (Canada, USA) and A. disjuncta sp. n. (Canada, USA) are described and A. socculata (Zetterstedt, 1847) is newly recorded from the Nearctic Region (USA: Alaska). Based on the phylogenetic analysis, four main clades/species groups are recognized within Arganthomyza, represented by the following species: A. barbarista Roháček, 2009 (A. barbarista group); A. setiplanta (Roháček, 1987), A. versitheca Roháček, 2009 and A. carbo sp. n. (A. setiplanta group); A. acuticuspis sp. n., A. bivittata sp. n. and A. duplex sp. n. (A. duplex group); A. disjuncta sp. n. and A. socculata (Zetterstedt) (A. socculata group). Considering the contemporary distribution and relationships of Arganthomyza species, it is hypothesized that the A. barbarista group and A. setiplanta group originated in East Asia while the A. duplex group and the A. socculata group each has its origin in the Nearctic Region.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11646/zootaxa.3604.1.1 | DOI Listing |
Adv Ther
December 2024
GSK, US Value Evidence and Outcomes, Collegeville, PA, 19426-0989, USA.
Introduction: Chronic obstructive pulmonary disease (COPD) is associated with exacerbations which can reduce quality of life and increase mortality. Single-inhaler triple therapy (SITT) is recommended for maintenance treatment of COPD among patients experiencing exacerbations despite dual-therapy use. This real-world comparative effectiveness study compared the impact of SITTs, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), and budesonide/glycopyrrolate/formoterol fumarate (BUD/GLY/FORM), on COPD exacerbations and mortality.
View Article and Find Full Text PDFTranspl Infect Dis
December 2024
Department of Surgery, NYU Grossman School of Medicine and Langone Health, New York, New York, USA.
Eur J Neurol
January 2025
Service de Génétique Médicale, CHU Bordeaux, Bordeaux, France.
Purpose: Heterozygous pathogenic variants in SPAST are known to cause Hereditary Spastic Paraplegia 4 (SPG4), the most common form of HSP, characterized by progressive bilateral lower limbs spasticity with frequent sphincter disorders. However, there are very few descriptions in the literature of patients carrying biallelic variants in SPAST.
Methods: Targeted Sanger sequencing, panel sequencing and exome sequencing were used to identify the genetic causes in 9 patients from 6 unrelated families with symptoms of HSP or infantile neurodegenerative disorder.
JPEN J Parenter Enteral Nutr
December 2024
Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Children use nasogastric tubes (NGTs) to ensure optimum nutrition and medication delivery when oral feeding fails or when they experience faltering growth. Although this method is less invasive, children may experience complications associated with NGTs. There is a gap in the literature regarding the types and prevention of complications of NGTs in the pediatric population at home.
View Article and Find Full Text PDFSkelet Muscle
December 2024
Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada.
Background: INTER- and INTRAmuscular fat (IMF) is elevated in high metabolic states and can promote inflammation. While magnetic resonance imaging (MRI) excels in depicting IMF, the lack of reproducible tools prevents the ability to measure change and track intervention success.
Methods: We detail an open-source fully-automated iterative threshold-seeking algorithm (ITSA) for segmenting IMF from T1-weighted MRI of the calf and thigh within three cohorts (CaMos Hamilton (N = 54), AMBERS (N = 280), OAI (N = 105)) selecting adults 45-85 years of age.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!